Want to join the conversation?
$SNX's cash used in operations was approx. $9MM in 3Q16. At the end of 3Q16, between cash and credit facilities, $SNX had over $1.4Bil available to fund growth. Capex for 3Q16 was $28MM, primarily due to continued Concentrix facility expansion. The trailing four quarters ROIC was 9.6%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.